OMedLive

ACCC Presentations

Cancer Immunotherapies


Presentations

  • NON
    CME

    "Testing" the Relationship Between Pathologists, Surgeons and Oncologists

    Speakers:Dan Raz, MD, MAS
    Jennie R. Crews, MD, MMM, FACP
    Jeffrey P. Gregg, MD

    Duration: 60 minutes

    Presented on: February 22, 2018

    *This session is not eligible for AMA PRA Category 1 CreditsTM


Speakers

  • Dan Raz, MD, MAS

    Dan Raz, MD, MAS

    Dan Raz, MD, MAS

    Dan Raz, MD, MAS, is a thoracic surgeon and co-director of the lung cancer and thoracic oncology program at City of Hope in Duarte, California. Dr Raz’s research focuses on developing therapies targeting specific epigenetic modifications in order to improve sensitivity to chemotherapy in lung cancer. He has authored dozens of articles, including studies demonstrating survival benefit for patients who choose lung cancer surgery. Dr Raz joined City of Hope in 2012 after completing fellowships at Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center and the Mayo Clinic. He earned his medical degree at the University of Pennsylvania, and a master’s degree in clinical research and biostatistics from the University of California, San Francisco.
  • Jennie R. Crews, MD, MMM, FACP

    Jennie R. Crews, MD, MMM, FACP

    Jennie R. Crews, MD, MMM, FACP

    Jennie R. Crews, MD, MMM, FACP, is medical director, Seattle Cancer Care Alliance Network and Research Integration, and an associate professor of medicine at the University of Washington. Dr Crews has over 18 years of experience in oncology in academic, private practice, and hospital-based settings. She is a fellow in the American College of Physicians, and is board-certified in internal medicine and medical oncology. She is on the editorial committee for the ACCC Drug Reference Guide, a reviewer for the Journal of Oncology Practice, and a member of the ASCO Practice Guidelines Implementation Network. She earned her medical degree from Duke University in Durham, North Carolina, where she also completed training in internal medicine and oncology, and served as assistant chief resident.
  • Jeffrey P. Gregg, MD

    Jeffrey P. Gregg, MD

    Jeffrey P. Gregg, MD

    Jeffrey Gregg, MD, is senior director of clinical pathology and molecular diagnostics, and professor of pathology at the University of California Davis School of Medicine and UC Davis Health. He is the director of the UC Davis Comprehensive Cancer Center Genomics Shared Resource, where he uses next-generation sequencing and genomic technologies for the analysis of tumors and biomarker discovery. Dr Gregg’s clinical and research focus is on developing liquid biopsy as a high-value clinical tool for cancer screening, diagnosis and surveillance. He is a member of the UC Davis Molecular Tumor Board and participates in other molecular tumor boards throughout the United States. Dr Gregg received his medical degree from the University of California, Los Angeles.